A Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Pharmacokinetics of Single Ascending Doses of CS6253 in Healthy Volunteers

Cogpep (CS6253) - Artery Therap, University of California Berkeley

Jan O. Johansson 1; Bengt Winblad 2; Daniel M. Michaelson 3; Henrik Zetterberg 4, 5; Jeffrey L. Cumming 6; Hussein N. Yassine 7

Aug 31, 2024